Gonadotropin-releasing hormone antagonist use in controlled ovarian stimulation and intrauterine insemination cycles in women with polycystic ovary syndrome

Fertility and Sterility

Volumn 93, Issue 4, 2010, Pages 1179-1184

  Ertunc, Devrim ^a   Tok, Ekrem C ^a   Savas, Aysun ^a   Ozturk, Ilay ^a   Dilek, Saffet ^a  

^a MERSIN UNIVERSITY   (Turkey)

Author keywords

GnRH antagonist; intrauterine insemination; Polycystic ovary syndrome

Indexed keywords

CHORIONIC GONADOTROPIN; GANIRELIX; GONADORELIN ANTAGONIST; LUTEINIZING HORMONE; PROSTAGLANDIN; PROSTAGLANDIN E2; RECOMBINANT FOLLITROPIN;

ADD ON THERAPY; ADULT; ANOVULATION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED OVARIAN STIMULATION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; FEMALE; FEMALE INFERTILITY; HOSPITAL COST; HUMAN; INTRAUTERINE INSEMINATION; LUTEINIZATION; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; OVARY CYCLE; OVARY FOLLICLE; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTAGLANDIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

ADULT; FEMALE; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; INFERTILITY, FEMALE; INSEMINATION, ARTIFICIAL, HOMOLOGOUS; MALE; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77049106675     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.11.030     Document Type: Article

References (28)

1. Adams J., Polson D.W., and Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. BMJ 293 (1986) 355-359
2. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril 89 (2008) 505-522
3. van Wely M., Fauser B.C., Laven J.S., Eijkemans M.J., and van der Veen F. Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome. Fertil Steril 86 (2006) 1710-1715
4. Ragni G., Vegetti W., Baroni E., Colombo M., Arnoldi M., Lombroso G., et al. Comparison of luteal phase profile in gonadotrophin stimulated cycles with or without a gonadotrophin-releasing hormone antagonist. Hum Reprod 16 (2001) 2258-2262
5. Williams R.S., Hillard J.B., De Vane G., Yeko T., Kipersztok S., Rhoton-Vlasak A., et al. A randomized, multicenter study comparing the efficacy of recombinant FSH vs recombinant FSH with ganirelix during superovulation/IUI therapy. Am J Obstet Gynecol 191 (2004) 648-651
6. Lambalk C.B., Leader A., Olivennes F., Fluker M.R., Andersen A.N., Ingerslev J., et al. Treatment with the GnRH antagonist ganirelix prevents premature LH rises and luteinization in stimulated intrauterine insemination: results of a double-blind, placebo-controlled, multicentre trial. Hum Reprod 21 (2006) 632-639
7. Crosignani P.G., Somigliana E., and Intrauterine Insemination Study Group. Effect of GnRH antagonists in FSH mildly stimulated intrauterine insemination cycles: a multicentre randomized trial. Hum Reprod 22 (2007) 500-505
8. Allegra A., Marino A., Coffaro F., Scaglione P., Sammartano F., Rizza G., et al. GnRH antagonist-induced inhibition of the premature LH surge increases pregnancy rates in IUI-stimulated cycles. A prospective randomized trial. Hum Reprod 22 (2007) 101-108
9. Gómez-Palomares J.L., Acevedo-Martín B., Chávez M., Manzanares M.A., Ricciarelli E., and Hernández E.R. Multifollicular recruitment in combination with gonadotropin-releasing hormone antagonist increased pregnancy rates in intrauterine insemination cycles. Fertil Steril 89 (2008) 620-624
10. Gómez-Palomares J.L., Juliá B., Acevedo-Martín B., Martínez-Burgos M., Hernández E.R., and Ricciarelli E. Timing ovulation for intrauterine insemination with a GnRH antagonist. Hum Reprod 20 (2005) 368-372
11. Checa M.A., Prat M., Robles A., and Carreras R. Use of gonadotropin-releasing hormone antagonists to overcome the drawbacks of intrauterine insemination on weekends. Fertil Steril 85 (2006) 573-577
12. Matorras R., Ramón O., Expósito A., Corcóstegui B., Ocerin I., Gonzalez-Lopera S., et al. Gn-RH antagonists in intrauterine insemination: the weekend-free protocol. J Assist Reprod Genet 23 (2006) 51-54
13. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81 (2004) 19-25
14. Al-Inany H.G., Abou-Setta A.M., and Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane review. Reprod Biomed Online 14 (2007) 640-649
15. Practice Committee of the American Society for Reproductive Medicine. Ovarian hyperstimulation syndrome. Fertil Steril 86 5 Suppl (2006) S178-S183
16. Bachmann M.O., Fairall L., Clark A., and Mugford M. Methods for analyzing cost effectiveness data from cluster randomized trials. Cost Eff Resour Alloc 5 (2007) 12
17. Tarlatzis B.C., Fauser B.C., Kolibianakis E.M., Diedrich K., Rombauts L., and Devroey P. GnRH antagonists in ovarian stimulation for IVF. Hum Reprod Update 12 (2006) 333-340
18. Kosmas I.P., Tatsioni A., Kolibianakis E.M., Verpoest W., Tournaye H., Van der Elst J., et al. Effects and clinical significance of GnRH antagonist administration for IUI timing in FSH superovulated cycles: a meta-analysis. Fertil Steril 90 (2008) 367-372
19. Lidor A.L., Goldenberg M., Cohen S.B., Seidman D.S., Mashiach S., and Rabinovici J. Management of women with polycystic ovary syndrome who experienced premature luteinization during clomiphene citrate treatment. Fertil Steril 74 (2000) 749-752
20. Yano T., Yano N., Matsumi H., Morita Y., Tsutsumi O., Schally A.V., et al. Effect of luteinizing hormone-releasing hormone analogs on the rat ovarian follicle development. Horm Res 48 Suppl 3 (1997) 35-41
21. Minaretzis D., Alper M.M., Oskowitz S.P., Lobel S.M., Mortola J.F., and Pavlou S.N. Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa lutein cells. Am J Obstet Gynecol 172 (1995) 1518-1525
22. Lin Y., Kahn J.A., and Hillensjo T. Is there a difference in the function of granulosa-luteal cells in patients undergoing in-vitro fertilization either with gonadotrophin-releasing hormone agonist or gonadotrophin-releasing hormone antagonist?. Hum Reprod 14 (1999) 885-888
23. Dada T., Salha O., Allgar V., and Sharma V. Utero-ovarian blood flow characteristics of pituitary desensitization. Hum Reprod 16 (2001) 1663-1670
24. Tan S.L., Zaidi J., Campbell S., Doyle P., and Collins W. Blood flow changes in the ovarian and uterine arteries during the normal menstrual cycle. Am J Obstet Gynecol 175 (1996) 625-631
25. Younis J.S., Matilsky M., Radin O., and Ben-Ami M. Increased progesterone/estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization-embryo transfer cycles with a long gonadotropin-releasing hormone agonist. Fertil Steril 76 (2001) 294-299
26. Ragni G., Caliari I., Nicolosi A.E., Arnoldi M., Somigliana E., and Crosignani P.G. Preventing high-order multiple pregnancies during controlled ovarian hyperstimulation and intrauterine insemination: 3 years' experience using low-dose recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. Fertil Steril 85 (2006) 619-624
27. Buyalos R.P., and Lee C.T. Polycystic ovary syndrome: pathophysiology and outcome with in vitro fertilization. Fertil Steril 65 (1996) 1-10
28. Segal S, Glatstein I, McShane P, Hotamisligil S, Ezcurra D, Carson R. Premature luteinization and in vitro fertilization outcome in gonadotropin/gonadotropin-releasing hormone antagonist cycles in women with polycystic ovary syndrome. Fertil Steril. In press.